Xenazine (Lundbeck Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Xenazine drug offered from Lundbeck Pharmaceuticals LLC. This Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lundbeck Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | tetrabenazine |
SUBSTANCE NAME: | TETRABENAZINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Vesicular Monoamine Transporter 2 Inhibitor [EPC],Vesicular Monoamine Transporter 2 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-11-24 |
END MARKETING DATE: | 0000-00-00 |
Xenazine HUMAN PRESCRIPTION DRUG Details:
Item Description | Xenazine from Lundbeck Pharmaceuticals LLC |
LABELER NAME: | Lundbeck Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5(mg/1) |
START MARKETING DATE: | 2008-11-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67386-421_fc606728-65eb-4e1b-a3e2-9c4fb513eddf |
PRODUCT NDC: | 67386-421 |
APPLICATION NUMBER: | NDA021894 |
Other TETRABENAZINE Pharmaceutical Manufacturers / Labelers: